“…The increasing use of screening breast MRI, especially among women with low or average-risk for breast cancer, raises concerns about the extent to which these studies trigger downstream cascades of care that may have limited value and entail potential harm for patients. 12 , 13 , 14 , 15 , 16 , 17 Breast MRI is less specific than mammography for breast pathology, 4 , 18 resulting in more false-positive results and unnecessary biopsies. 19 , 20 , 21 In addition, unlike mammography, breast MRI can reveal extramammary findings that may similarly prompt follow-up imaging and other services of unclear benefit.…”